This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
GEHC Stock May Rise on Freelium Magnet Launch, Boosts MR Access
by Zacks Equity Research
GE HealthCare unveils Freelium, a next-gen sealed magnet platform designed to revolutionize MR imaging with minimal helium usage.
GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GE HealthCare (GEHC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for GE HealthCare (GEHC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises
by Zacks Equity Research
GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
GE HealthCare (GEHC) delivered earnings and revenue surprises of 15.08% and 0.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
by Zacks Equity Research
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
PAHC vs. GEHC: Which Stock Is the Better Value Option?
by Zacks Equity Research
PAHC vs. GEHC: Which Stock Is the Better Value Option?
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of 5.17% and 1.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
GEHC Stock May Rise With $138M Investment in Cork Facility Expansion
by Zacks Equity Research
GE HealthCare invests $138M to expand its Cork facility to enhance manufacturing capacity for life-saving imaging contrast media and strengthen its global supply chain.
GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series
by Zacks Equity Research
GE HealthCare launches the enhanced Voluson Expert Series to advance women's health with faster, more precise imaging for improved care in obstetrics and gynecology.
Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch
by Indrajit Bandyopadhyay
As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.
Hologic's Q1 Earnings Coming Up: How to Play the Stock?
by Moumi Mondal
In the first quarter of fiscal 2025, HOLX is expected to have benefited from the strength of its core franchises.
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?
by Debanjana Dey
TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
GEHC Stock Gains on the Collaborated Launch of Care Innovation Hub
by Zacks Equity Research
GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California, San Francisco.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Reasons to Add GE HealthCare Stock to Your Portfolio Now
by Zacks Equity Research
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
by Zacks Equity Research
GE HealthCare announces a seven-year strategic collaboration with Sutter Health.
GEHC or PODD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEHC vs. PODD: Which Stock Is the Better Value Option?
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
GEHC vs. PODD: Which Stock Is the Better Value Option?
by Zacks Equity Research
GEHC vs. PODD: Which Stock Is the Better Value Option?
5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More
by Indrajit Bandyopadhyay
Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care.